GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a significant focus in healthcare investigation, largely due to its remarkable impact on treating conditions such as type 2 diabetes and excess body fat. New trials have shown that in addition to glucose control, GLP-1… Read More